Metraipolis › archive › dc_8fd145cbffab

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity — Europe PMC PMID:41562407

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41562407
DOI: 10.1002/1878-0261.70210
License (as archived): solo-consultazione
Archived: 2026-11-06T15:36:57.847Z
SHA-256 of the archived text: 396aec1c53bbb8c6b86062b325a850039db70f74b7279b28dcfcff4338be2820
Stable URL of this page: https://metraipolis.com/documento/dc_8fd145cbffab

How to cite

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity — Europe PMC PMID:41562407 — Europe PMC (en), https://europepmc.org/article/MED/41562407 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8fd145cbffab (Metraipolis archive dc_8fd145cbffab, sha256 396aec1c53bbb8c6b86062b325a850039db70f74b7279b28dcfcff4338be2820)

BibTeX

@misc{dc8fd145cbffab,
  title = {Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity — Europe PMC PMID:41562407},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41562407},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8fd145cbffab; sha256 396aec1c53bbb8c6b86062b325a850039db70f74b7279b28dcfcff4338be2820},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41562407. Agents can read the archived copy with the MCP tool read_document.